Latest News

Diabetes drug shows promise in reducing Alzheimer's disease in an experimental model

The diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease in the brain and improves learning and memory in two experimental Alzheimer's disease models, researchers have discovered. These results also found Alzheimer's disease patients have a lower level of amylin in blood compared to those without this disease, and may provide a new avenue for both treatment and diagnosis of Alzheimer's disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Should you should talk to strangers? Doing so increases positive experience, study shows

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  • Good news for aging population: Incidence of stroke in elderly has dropped by 40% over last 20 years

  • You should talk to strangers: Doing so increases positive experience, study shows

  • High rates of violence suffered by unstably housed women in San Francisco

  • Mothers of Children with Autism Benefit From Peer-Led Intervention

  • Children's impulsive behaviour is related to brain connectivity

  • Innovative system anticipates driver fatigue in the vehicle to prevent accidents

  • Rigid connections: Molecular basis of age-related memory loss explained

  • Low strength brain stimulation may be effective for depression

  •